Title | Type | SJR | H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2016) | %Female (2016) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Journal for ImmunoTherapy of Cancer | journal | 2.668 Q1 | 117 | 90 | 146 | 3979 | 767 | 138 | 5.18 | 44.21 | 33.73 | |
2 | Perspectives in Medicinal Chemistry | journal | 2.425 Q1 | 17 | 2 | 8 | 277 | 83 | 8 | 10.38 | 138.50 | 40.00 | |
3 | International Journal of Neuropsychopharmacology | journal | 1.997 Q1 | 125 | 118 | 598 | 6544 | 2678 | 587 | 4.38 | 55.46 | 40.10 | |
4 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 1.836 Q1 | 47 | 39 | 86 | 2201 | 440 | 86 | 5.43 | 56.44 | 42.08 | |
5 | PharmacoEconomics | journal | 1.797 Q1 | 118 | 112 | 311 | 4712 | 1002 | 258 | 3.45 | 42.07 | 38.50 | |
6 | Frontiers in Pharmacology | journal | 1.729 Q1 | 154 | 515 | 725 | 33384 | 3101 | 671 | 4.37 | 64.82 | 43.94 | |
7 | Diabetes, Metabolic Syndrome and Obesity | journal | 1.586 Q1 | 64 | 45 | 168 | 2511 | 744 | 165 | 4.42 | 55.80 | 38.10 | |
8 | CNS Neuroscience and Therapeutics | journal | 1.567 Q1 | 91 | 128 | 425 | 6031 | 1514 | 324 | 3.34 | 47.12 | 43.92 | |
9 | Infection and Drug Resistance | journal | 1.551 Q1 | 65 | 33 | 101 | 1683 | 449 | 101 | 4.89 | 51.00 | 36.27 | |
10 | Expert Review of Vaccines | journal | 1.482 Q1 | 105 | 141 | 416 | 11331 | 1366 | 386 | 3.31 | 80.36 | 41.82 | |
11 | Vaccines | journal | 1.457 Q1 | 85 | 48 | 95 | 4565 | 385 | 92 | 4.08 | 95.10 | 52.08 | |
12 | Therapeutic Advances in Neurological Disorders | journal | 1.442 Q1 | 68 | 47 | 86 | 2043 | 394 | 82 | 4.87 | 43.47 | 36.40 | |
13 | Pharmacogenomics and Personalized Medicine | journal | 1.208 Q1 | 37 | 15 | 67 | 912 | 289 | 67 | 4.76 | 60.80 | 40.48 | |
14 | Cancer Chemotherapy and Pharmacology | journal | 1.204 Q1 | 122 | 276 | 884 | 9340 | 2810 | 873 | 2.96 | 33.84 | 32.58 | |
15 | Cancer Biology and Therapy | journal | 1.181 Q1 | 130 | 144 | 553 | 5905 | 1738 | 522 | 3.16 | 41.01 | 41.98 | |
16 | Pharmacognosy Reviews (discontinued) | journal | 1.140 Q1 | 68 | 20 | 68 | 1475 | 314 | 67 | 4.72 | 73.75 | 51.02 | |
17 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.127 Q1 | 57 | 59 | 184 | 2833 | 510 | 179 | 2.95 | 48.02 | 24.87 | |
18 | Cardiovascular Therapeutics | journal | 1.095 Q1 | 54 | 58 | 168 | 2165 | 424 | 161 | 2.53 | 37.33 | 31.96 | |
19 | Current Pharmaceutical Design | journal | 1.069 Q2 | 183 | 581 | 1906 | 75638 | 5822 | 1740 | 2.73 | 130.19 | 38.67 | |
20 | Asian Journal of Pharmaceutical Sciences | journal | 1.006 Q2 | 66 | 183 | 148 | 2756 | 626 | 145 | 4.06 | 15.06 | 41.89 | |
21 | Journal of Physiology and Pharmacology | journal | 1.003 Q2 | 89 | 90 | 271 | 4954 | 866 | 271 | 3.29 | 55.04 | 52.42 | |
22 | Journal of Pharmacological Sciences | journal | 1.000 Q2 | 101 | 118 | 410 | 3638 | 1097 | 409 | 2.78 | 30.83 | 29.58 | |
23 | Drug Design, Development and Therapy | journal | 0.993 Q2 | 94 | 363 | 908 | 15594 | 2911 | 893 | 3.04 | 42.96 | 37.71 | |
24 | Core Evidence (discontinued) | journal | 0.965 Q2 | 29 | 5 | 28 | 371 | 116 | 27 | 4.24 | 74.20 | 43.75 | |
25 | Human Vaccines and Immunotherapeutics | journal | 0.957 Q2 | 93 | 442 | 1316 | 18531 | 2768 | 1093 | 2.00 | 41.93 | 47.76 | |
26 | BMC pharmacology & toxicology | journal | 0.940 Q2 | 43 | 62 | 180 | 2499 | 525 | 177 | 2.81 | 40.31 | 37.34 | |
27 | Altex | journal | 0.911 Q2 | 64 | 40 | 127 | 2158 | 412 | 107 | 2.84 | 53.95 | 44.12 | |
28 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.873 Q2 | 92 | 317 | 427 | 14565 | 1503 | 426 | 3.71 | 45.95 | 43.07 | |
29 | Pharmacological Reports | journal | 0.866 Q2 | 98 | 191 | 522 | 8952 | 1517 | 519 | 2.77 | 46.87 | 52.83 | |
30 | Biomedicine and Pharmacotherapy | journal | 0.864 Q2 | 149 | 717 | 564 | 32380 | 1703 | 561 | 3.05 | 45.16 | 43.00 | |
31 | Journal of Food and Drug Analysis | journal | 0.817 Q2 | 79 | 104 | 255 | 4068 | 733 | 250 | 3.42 | 39.12 | 40.44 | |
32 | Current Therapeutic Research | journal | 0.776 Q2 | 46 | 7 | 94 | 143 | 287 | 90 | 3.15 | 20.43 | 15.38 | |
33 | Drugs in Context | journal | 0.718 Q2 | 36 | 11 | 40 | 375 | 118 | 36 | 3.81 | 34.09 | 30.65 | |
34 | Saudi Pharmaceutical Journal | journal | 0.715 Q2 | 76 | 90 | 229 | 3028 | 670 | 221 | 2.51 | 33.64 | 35.16 | |
35 | Journal of Toxicology | journal | 0.714 Q2 | 47 | 23 | 75 | 1263 | 169 | 75 | 2.02 | 54.91 | 43.18 | |
36 | Journal of Pharmacology and Pharmacotherapeutics | journal | 0.709 Q2 | 42 | 47 | 232 | 847 | 345 | 160 | 1.09 | 18.02 | 38.54 | |
37 | Biomarker Insights | journal | 0.699 Q2 | 40 | 29 | 97 | 1744 | 195 | 95 | 1.79 | 60.14 | 44.79 | |
38 | Korean Journal of Physiology and Pharmacology | journal | 0.680 Q2 | 40 | 73 | 219 | 2723 | 435 | 219 | 2.21 | 37.30 | 36.73 | |
39 | Drug Metabolism and Pharmacokinetics | journal | 0.673 Q2 | 75 | 63 | 222 | 2207 | 494 | 206 | 2.20 | 35.03 | 32.83 | |
40 | DARU, Journal of Pharmaceutical Sciences | journal | 0.614 Q3 | 58 | 24 | 211 | 747 | 475 | 194 | 2.05 | 31.13 | 38.53 | |
41 | International Journal of Immunopathology and Pharmacology | journal | 0.596 Q3 | 65 | 104 | 297 | 3333 | 519 | 289 | 1.90 | 32.05 | 45.20 | |
42 | Journal of Pharmacy and Pharmaceutical Sciences | journal | 0.592 Q3 | 88 | 40 | 156 | 3079 | 363 | 155 | 1.73 | 76.98 | 43.75 | |
43 | Pharmaceutical Biology | journal | 0.575 Q3 | 88 | 394 | 676 | 16529 | 1390 | 676 | 1.98 | 41.95 | 45.30 | |
44 | Drugs in R and D | journal | 0.563 Q3 | 54 | 36 | 107 | 1399 | 237 | 104 | 2.26 | 38.86 | 29.56 | |
45 | Chinese Medicine | journal | 0.551 Q3 | 56 | 48 | 88 | 2265 | 169 | 86 | 1.75 | 47.19 | 39.29 | |
46 | Drug, Healthcare and Patient Safety | journal | 0.531 Q3 | 30 | 13 | 66 | 469 | 112 | 60 | 1.95 | 36.08 | 40.48 | |
47 | Indian Journal of Pharmacology | journal | 0.433 Q3 | 68 | 178 | 481 | 3246 | 547 | 400 | 1.13 | 18.24 | 36.65 | |
48 | Pharmacognosy Research (discontinued) | journal | 0.432 Q3 | 44 | 66 | 180 | 2003 | 277 | 179 | 1.48 | 30.35 | 37.55 | |
49 | Open Medicinal Chemistry Journal | journal | 0.431 Q3 | 23 | 4 | 14 | 187 | 31 | 14 | 2.14 | 46.75 | 6.67 | |
50 | International Journal of PharmTech Research (discontinued) | journal | 0.411 Q3 | 54 | 464 | 872 | 15204 | 1907 | 872 | 2.72 | 32.77 | 46.84 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®